Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

Such guidance shall include, but not be limited to, the services of the following consultants:
[***]
Orexigen acknowledges that upon execution of the License Agreement, Cypress intends to schedule a kick off meeting and that Orexigen agrees to provide the services of [***] and its consultants at such meeting and any other meetings that are convened to discuss the clinical proof of concept studies; providing, that, Cypress schedules such meetings after consulting with [***] as to times and locations.
 
***   Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.